BALA CYNWYD, Pa., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Altra Industrial Motion Corp. (Nasdaq - AIMC)
Under the terms of the agreement, Altra will be acquired by Regal Rexnord Corporation (“Regal Rexnord”). Regal Rexnord will acquire each outstanding share of Altra for $62.00 per share, in an all-cash transaction valued at approximately $5.0 billion on an enterprise value basis. The investigation concerns whether the Altra Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Regal Rexnord is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/altra-industrial-motion-corp-nasdaq-aimc/.
UserTesting, Inc. (NYSE - USER)
Under the terms of the agreement, UserTesting will be acquired by Thoma Bravo and Sunstone Partners (“Buyers”). Buyers will acquire each outstanding share of UserTesting for $7.50 per share, in an all-cash transaction valued at approximately $1.3 billion. The investigation concerns whether the UserTesting Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Buyers are paying too little for the Company. For example, the deal consideration is below the 52-week high of $15.98 for the Company’s shares.
Additional information can be found at https://www.brodskysmith.com/cases/usertesting-inc-nyse-user/.
AVEO Pharmaceuticals, Inc. (Nasdaq - AVEO)
Under the terms of the agreement, AVEO will be acquired by LG Chem, Ltd. (“LG Chem”). LG Chem will pay $15.00 a share in cash for all outstanding shares of AVEO. The deal has an implied equity value of $566 million. The investigation concerns whether the AVEO Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether LG Chem is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/aveo-pharmaceuticals-inc-nasdaq-aveo/.
Limestone Bancorp, Inc. (Nasdaq - LMST)
Under the terms of the agreement, Limestone will be acquired by Peoples Bancorp Inc. (“Peoples”) (Nasdaq - PEBO). Under the terms of the Merger Agreement, shareholders of Limestone will receive 0.90 shares of Peoples common stock for each share of Limestone common stock. Based on Peoples' closing price of $30.28 per share as of October 21, 2022, the aggregate deal value is approximately $208.2 million, or $27.25 per share. The investigation concerns whether the Limestone Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Peoples is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/limestone-bancorp-inc-nasdaq-lmst/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
